Evidence map›Paper›PMID 36269456›Full record

ArticleJournal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry2022

An unprecedented function for a tungsten-containing oxidoreductase.

Liju G Mathew, Dominik K Haja, Clayton Pritchett, Winston McCormick, Robbie Zeineddine, Leo S Fontenot, Mario E Rivera, John Glushka, Michael W W Adams, William N Lanzilotta

Open access · greenAbstract read
In one paragraph

Article in Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. An electron-bifurcating "plug" to a protein nanowire in tungsten-dependent aldehyde detoxification.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Review
  6. Tungsten is utilized for lactate consumption and SCFA production by a dominant human gut microbeProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Liju G Mathew *Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA, 30602, USA.
Dominik K Haja *Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA, 30602, USA.
Clayton PritchettDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA, 30602, USA.
Winston McCormickDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA, 30602, USA.
Robbie ZeineddineDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA, 30602, USA.
Leo S FontenotDepartment of Chemistry, Louisiana State University, Baton Rouge, LA, 70803, USA.
Mario E RiveraDepartment of Chemistry, Louisiana State University, Baton Rouge, LA, 70803, USA.
John GlushkaDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA, 30602, USA.
Michael W W AdamsDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA, 30602, USA. adamsm@uga.edu.
William N LanzilottaDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA, 30602, USA. wlanzilo@uga.edu.ORCID 0000-0002-4852-321X
University of Georgia · USLouisiana State University · US

Funding

W-Health: Tungsten is an Essential Metal for a Healthy Gut MicrobiomeR01GM136885 · NIGMS · UNIVERSITY OF GEORGIA · PI ADAMS, MICHAEL W. · 2020 to 2023
$2.0M
A radical new paradigm for heme degradation in enteric pathogensR01GM124203 · NIGMS · UNIVERSITY OF GEORGIA · PI LANZILOTTA, WILLIAM N · 2017 to 2020
$1.3M
NIGMS NIH HHS R01 GM124203NIGMS NIH HHS R01GM124203NIGMS NIH HHS R01 GM136885
6 · The paper itself

Abstract

Five tungstopterin-containing oxidoreductases were characterized from the hyperthermophile Pyrococcus furiosus. Each enzyme catalyzes the reversible conversion of one or more aldehydes to the corresponding carboxylic acid, but they have different specificities. The physiological functions of only two of these enzymes are known: one, termed GAPOR, is a glycolytic enzyme that oxidizes glyceraldehyde-3-phosphate, while the other, termed AOR, oxidizes multiple aldehydes generated during peptide fermentation. Two of the enzymes have known structures (AOR and FOR). Herein, we focus on WOR5, the fifth tungstopterin enzyme to be discovered in P. furiosus. Expression of WOR5 was previously shown to be increased during cold shock (growth at 72 ℃), although the physiological substrate is not known. To gain insight into WOR5 function, we sought to determine both its structure and identify its intracellular substrate. Crystallization experiments were performed with a concentrated cytoplasmic extract of P. furiosus grown at 72 ℃ and the structure of WOR5 was deduced from the crystals that were obtained. In contrast to a previous report, WOR5 is heterodimeric containing an additional polyferredoxin-like subunit with four [4Fe-4S] clusters. The active site structure of WOR5 is substantially different from that of AOR and FOR and the significant electron density observed adjacent to the tungsten cofactor of WOR5 was modeled as an aliphatic sulfonate. Biochemical assays and product analysis confirmed that WOR5 is an aliphatic sulfonate ferredoxin oxidoreductase (ASOR). A catalytic mechanism for ASOR is proposed based on the structural information and the potential role of ASOR in the cold-shock response is discussed.

Indexed as

Pyrococcus furiosusTungstenAldehyde OxidoreductasesAldehydesOxidoreductasesAldehyde OxidoreductasesAldehydesOxidoreductasesTungstenAliphatic sulfonatesCold response proteinCrystal structurePyrococcus furiosusTaurineTungstoenzymeWOR5

Identifiers

PMID36269456
PMCPMC10293930
OpenAlexW4307027203

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.